- decreased susceptibility to autoimmune diabetes / MGI
- periinsulitis / MGI
- decreased physiological sensitivity to xenobiotic / MGI
- decreased hematocrit / MGI
- abnormal liver physiology / MGI
- abnormal T cell differentiation / MGI
- abnormal cytokine secretion / MGI
- increased autoantibody level / MGI
- decreased susceptibility to parasitic infection / MGI
FVB/N(Cg)-H2b/Orl
Status | Available to order |
EMMA ID | EM:15300 |
International strain name | FVB/N(Cg)-H2b/Orl |
Alternative name | FVBN/H2b |
Strain type | Other |
Allele/Transgene symbol | H2b |
Gene/Transgene symbol | H2 |
Information from provider
Provider | Douglas hanahan |
Provider affiliation | SV, EPFL/ISREC/Ludwig Lausanne |
Genetic information | FVB/N-H2b |
Phenotypic information | Homozygous:These mice do not develop abnormal phenotypes. They are inbred mice of the FVB/N genetic background that are homozygous congenic for the H2b MHC locus.Heterozygous:Not applicable. |
Breeding history | C57BL/6 (H2b) mice were bred with FVB/N mice, and the F1 mice were backcrossed to FVB/N to generate mice congenic for the H2b MHC locus but otherwise genetically FVB/N. Thus the F1 mice were backcrossed for 11 generations to FVB/N, selecting for the H2b locus in every generation by flow cytometry analyses of H2Kb and H2Db. Subsequently, N11 backcross mice were intercrossed to generate homozygous H2b mice, expressing H2Kb and H2Db, but not H2Kq and H2D/Lq. The homozygous H2b congenics were then established as an inbred line by breeding males and females of this genotype. More than 20 crosses. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | yes |
Immunocompromised | no |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | homozygous FVB/N, homozygous FVB/N |
Stage of embryos | 2-cell |
Disease and phenotype information
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- decreased hematocrit / MGI
- abnormal liver physiology / MGI
- abnormal T cell differentiation / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal immunoglobulin level / MGI
- increased IgM level / MGI
- abnormal cytokine secretion / MGI
- thyroid inflammation / MGI
- increased autoantibody level / MGI
- insulitis / MGI
- increased susceptibility to autoimmune diabetes / MGI
- decreased susceptibility to autoimmune diabetes / MGI
- decreased susceptibility to parasitic infection / MGI
- immune system phenotype / MGI
- periinsulitis / MGI
- abnormal T cell number / MGI
- decreased CD4-positive, alpha beta T cell number / MGI
- increased CD8-positive, alpha-beta T cell number / MGI
- decreased IgG1 level / MGI
- decreased IgG2a level / MGI
- increased physiological sensitivity to xenobiotic / MGI
- decreased physiological sensitivity to xenobiotic / MGI
- increased sensitivity to induced morbidity/mortality / MGI
Literature references
- Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers.;Galliverti Gabriele, Wullschleger Stephan, Tichet Mélanie, Murugan Dhaarini, Zangger Nadine, Horton Wesley, Korman Alan J, Coussens Lisa M, Swartz Melody A, Hanahan Douglas, ;2020;Cancer immunology research;8;131-145; 31771984
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).